4.6 Article

Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin chronic obstructive pulmonary disease subjects

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Therapeutic Role for Mannose-Binding Lectin in Cigarette Smoke-Induced Lung Inflammation? Evidence from a Murine Model

Sandra Hodge et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)

Article Respiratory System

Defective macrophage phagocytosis of bacteria in COPD

A. E. Taylor et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Article Critical Care Medicine

Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations

Terence A. R. Seemungal et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Critical Care Medicine

Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease

Sandra Hodge et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Biochemistry & Molecular Biology

Smoking alters alveolar macrophage recognition and phagocytic ability

Sandra Hodge et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)

Article Respiratory System

Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages

S. Hodge et al.

EUROPEAN RESPIRATORY JOURNAL (2006)

Article Respiratory System

Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation

S Hodge et al.

EUROPEAN RESPIRATORY JOURNAL (2005)

Article Critical Care Medicine

Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease

TMA Wilkinson et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)

Article Critical Care Medicine

Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferon)

A Prieto et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)